medigraphic.com
SPANISH

Revista del Hospital Juárez de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 4

<< Back Next >>

Rev Hosp Jua Mex 2019; 86 (4)

Correlation of fasting serum glucose and HbA1c in teachers of Health Sciences of the UV Region Veracruz

Torres‑Hernández RM, González‑Jiménez B, Hernández-Ojeda H, Martínez‑Sibaja C, Cruz‑Vergara IG, Linares‑Tenorio D
Full text How to cite this article

Language: Spanish
References: 18
Page: 172-176
PDF size: 200.90 Kb.


Key words:

Serum glucose, HbA1c, prediabetes, diabetes.

ABSTRACT

Objective: To determine the correlation of HbA1c and fasting glucose in teachers of the area of ​​Health Sciences of the Universidad Veracruzana. Material and methods: Observational, transversal, analytical study in professors of the Faculties of the Health Sciences area of the Universidad Veracruzana. With prior informed consent. The automated clinical chemistry analyzer H-100 was used for the HbA1c tests, blood chemistry, the abdominal perimeter and BMI were measured. Results: Teachers sex 34 (43.59%) male and 44 (56.41%) female. Physical Education Sports and Recreation 16 (22%), Faculty of Nursing 10 (12%), Faculty of Nutrition 8 (10%), Faculty of Medicine 20 (24%), Faculty of Chiropractic 8 (10%) and Faculty of Psychology 16 (22%). The Pearson correlation for non-diabetics was r = 0.173 with value p = 0.190, the pre-diabetic correlation of r = 0.853 with value p ‹ 0.001 and for the group of diabetics r = 0.621 with value p = 0.100 with the HbA1c test, 9 (11.54%) pre diabetic and 4 (5.13%) with diabetes not previously diagnosed. Conclusions: HbA1c, as a predictive indicator of glucose during the last three months, showed the presence of prediabetes in a group of teachers with Hb1Ac 5.98 ± 0.19.


REFERENCES

  1. Informe Mundial sobre la Diabetes. [Internet] Geneva: Organización Mundial de la salud. 2016; 6. [Citado el 5 de enero del 2017] Disponible en: http://apps.who.int/iris/bitstream/10665/254649/1/9789243565255-spa.pdf?ua=1

  2. Hernández AM, Gutiérrez JP, Reynoso-Noverón N. Diabetes mellitus en México. El estado de la epidemia. Salud Publica Mex. 2013; 55(Suppl. 2): S129-36.

  3. Romero-Martínez M, Shamah-Levy T, Franco-Núñez A, Villalpando S, Cuevas-Nasu L, Gutiérrez JP, et al. Encuesta Nacional de Salud y Nutrición 2012: diseño y cobertura. Salud Publica Mex. 2013; 55: S332-40.

  4. Vargas EA, Gómez JH, Conde JM. Medición de la hemoglobina glucosilada capilar como tamizaje en diabetes mellitus tipo 2. Med Int Méx. 2014; 30: 538-45.

  5. Carrera ITA CA, Martinez JM. Pathophysiology of diabetes mellitus type 2: beyond the duo “insulin resistance-secretion deficit”. Nutr Hosp. 2013; 28: 78-87.

  6. Campuzano-Maya G, Latorre-Sierra G. La HbA1c en el diagnóstico y en el manejo de la diabetes. Medicina & Laboratorio: 2010; 16: 211-241.

  7. López R, Fuentes R, Gonzalez ME, et al. Diabetic by HbA1c, normal by OGTT: a frequent finding in the Mexico city diabetes study. J Endocr Soc. 2017: 1-12.

  8. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA1c: Analysis of glucose profiles and HbA1c in the diabetes control and complications trial. Diabetes Care. 2002; 25: 275-8.

  9. Castro M, Godínez G, Liceaga C, et al. Manejo de la hiperglucemia en el paciente hospitalizado. Med Int Mex. 2012; 28: 124-53.

  10. Fernandez MA, Santiago AM, Moreno A. Carramiñana FC. López F. Miravet S. et al. Guías clínicas diabetes mellitus: SEMERGEN. 2015; pp. 4-5.

  11. Lara A. Epidemiología y perspectivas de la diabetes mellitus tipo 2 en México. En: Dra Natalia Guadalupe Tripp Arreguín, editor. Endocrinología clínica de Dorantes y Martínez. 5ta edición. México DF; Manual moderno, 2016. pp. 391-6.

  12. International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2015.

  13. Múnera MI, Restrepo MA, et al. Hemoglobina glucosilada A1c vs glucemia plasmática en ayunas de pacientes ambulatorios de un laboratorio médico. Rev Salud Pública. 2011; 13: 1-10.

  14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-9.

  15. Birules Pons, I. Fernández Fernández. Criterios de cribado y diagnóstico de diabetes mellitus. Aten Primaria 2003; 3: 334-6.

  16. Rodríguez LM, Mendoza CM. Riesgo de diabetes mellitus tipo 2, sobrepeso y obesidad en adultos del distrito de barranquilla. Rev Salud Pública Nutr. 2018; 17: 132-36.

  17. Bello-Zambrano HI, Vinueza-Lescano ME. Pacientes con sobrepeso y obesos. Morbilidad oculta de prediabetes y diabetes mellitus de tipo 2. Dom Cien. 2017; 3838-847. http://dominiodelasciencias.com/ojs/index.php/es/index.

  18. Felix JB, Gómez GB, Ramirez AC, et al. Ajuste de la cifra de hemoglobin glucosilada para el diagnóstico de diabetes mellitus en México. Med Int Mex. 2018; 34: 196-203.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Hosp Jua Mex. 2019;86